Systembio Distributor

Gliadin Antibody Iga Neuroendocrine Tumor

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

BNC941524-100 100uL
EUR 238.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF594 conjugate, Concentration: 0.1mg/mL

Iga Antibody Laboratories manufactures the gliadin antibody iga neuroendocrine tumor reagents distributed by Genprice. The Gliadin Antibody Iga Neuroendocrine Tumor reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact iga antibody. Other Gliadin products are available in stock. Specificity: Gliadin Category: Antibody Group: Iga Neuroendocrine

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

100uL
EUR 238.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680R conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

500uL
EUR 652.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF680R conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

100uL
EUR 238.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF770 conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

500uL
EUR 652.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF770 conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

100uL
EUR 238.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF488A conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

500uL
EUR 652.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF488A conjugate, Concentration: 0.1mg/mL

NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524) Antibody

100uL
EUR 238.8
Description: Primary antibody against NKX2.2 (Neuroendocrine and Ewing's Sarcoma Marker) (NX2/1524),CF405M conjugate, Concentration: 0.1mg/mL

Iga Neuroendocrine information

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNCH2552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNCB2552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Biotin conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNCB2552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Biotin conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNUB2552-100 100uL
EUR 316.8
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Concentration: 0.2mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNUB2552-50 50uL
EUR 486
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), 1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNUB2552-500 500uL
EUR 615.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), Concentration: 0.2mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC472552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC472552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF647 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC552552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC552552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF555 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC612552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC612552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF660R conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC432552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF543 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC432552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF543 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC682552-100 100uL
EUR 279.6
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF568 conjugate, Concentration: 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552) Antibody

BNC682552-500 500uL
EUR 654
Description: Primary antibody against AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2552), CF568 conjugate, Concentration: 0.1mg/mL

Multiple organs neuroendocrine tumor tissue array with normal tissue

NE841 each
EUR 354
Description: Multiple organs neuroendocrine tumor tissue array with normal tissue